but were excluded if they had received either study inhaler or an inhaled corticosteroid-LAMA-LABA combination via separate inhalers. The cohort included 87,751 individuals, from which ...

are among the first data to show that a combination of a long-acting muscarinic antagonist (LAMA) and long-acting beta agonist (LABA) is more effective than a LABA combined with an inhaled ...

rescue inhaler to next-generation SMART meds that combine an inhaled corticosteroid with a long-acting bronchodilator (LABA). The medications inside inhalers work in different ways and are ...

in a single inhaler, AZ paid Pearl Therapeutics $1.15 billion for Bevespi. In Japan, Novartis’ Ultibro and GlaxoSmithKline’s LAMA/LABA combination Anoro, are approved in COPD maintenance.

a triple-therapy inhaler containing an inhaled corticosteroid (ICS), a long-acting muscarinic antagonist (LAMA), and a long-acting beta-agonist (LABA), was found to offer comparable or incremental ...

Inhaled corticosteroids (ICS), short- and long-acting β 2-agonists (SABA and LABA), long-acting muscarinic antagonists (LAMA ... or without ICS (preferably in combination), followed with oxygen ...

Inhaled anticholinergic agents or SAMA such ... remain unconvinced that ICS are effective and recommend only LAMA + LABA combination bronchodilator therapy. Based on our experience, COPD patients ...